Risultati della ricerca - Sutton, Kenneth C

Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of Study di Sutton, Kenneth C, De Vente, Jerome, Leblanc, Roger, Dejesus, Edwin, Smith, Graham, Mills, Anthony, Baril, Jean-Guy, St. Clair, Marty, Stancil, Britt S, Vandermeulen, Kati, Spreen, William R

Testo Testo Testo

Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy di Mills, Anthony, Richmond, Gary J., Newman, Cheryl, Osiyemi, Olayemi, Cade, Jerry, Brinson, Cynthia, De Vente, Jerome, Margolis, David A., Sutton, Kenneth C., Wilches, Viviana, Hatch, Sarah, Roberts, Jeremy, McCoig, Cynthia, Garris, Cindy, Vandermeulen, Kati, Spreen, William R.

Testo Testo Testo

Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study di Smith, Graham H R, Henry, W Keith, Podzamczer, Daniel, Masiá, Maria Del Mar, Bettacchi, Christopher J, Arasteh, Keikawus, Jaeger, Hans, Khuong-Josses, Marie-Aude, Montes-Ramírez, Maria Luisa, Stellbrink, Hans-Jürgen, Yazdanpanah, Yazdan, Richmond, Gary J, Sutton, Kenneth C, Zhang, Feifan, McCoig, Cynthia C, St Clair, Marty H, Vandermeulen, Kati, Van Solingen-Ristea, Rodica, Smith, Kimberly Y, Margolis, David A, Spreen, William R

Testo Testo Testo